Verastem reported $76.87M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
AbbVie USD 62.48B 2.05B Jun/2026
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
AstraZeneca USD 28.8B 2.79B Sep/2026
Curis USD 29.43M 10.69M Jun/2024
Cytokinetics USD 244.33M 3.87M Sep/2026
Gilead Sciences USD 23.82B 17M Sep/2026
Incyte USD 28.42M 994K Jun/2026
Laboratory Of America USD 5.31B 607.4M Sep/2026
Novartis USD 38.38B 893M Sep/2026
Pfizer USD 60B 498M Sep/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
TG Therapeutics USD 745.63M 247K Sep/2026
Verastem USD 76.87M 4.46M Mar/2026